Cooper EBITDA 2010-2024 | COO

Cooper EBITDA for the quarter ending July 31, 2024 was $0.282B, a 14.38% increase year-over-year.

  • Cooper 2023 EBITDA was 0.901B, a 5.52% increase from 2022.
  • Cooper 2022 EBITDA was 0.854B, a 4.74% increase from 2021.
  • Cooper 2021 EBITDA was 0.815B, a 36.1% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Cooper EBITDA 2010-2024 | COO

  • Cooper 2023 EBITDA was 0.901B, a 5.52% increase from 2022.
  • Cooper 2022 EBITDA was 0.854B, a 4.74% increase from 2021.
  • Cooper 2021 EBITDA was 0.815B, a 36.1% increase from 2020.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$71.2B
Becton Dickinson (BDX)$69.4B
Cardinal Health (CAH)$28B
West Pharmaceutical Services (WST)$23.9B
Labcorp (LH)$19.6B
Align Technology (ALGN)$16.8B
Henry Schein (HSIC)$8.9B
Merit Medical Systems (MMSI)$6B
DENTSPLY SIRONA (XRAY)$4.9B
CONMED (CNMD)$2.3B
Patterson (PDCO)$1.9B
STAAR Surgical (STAA)$1.5B
Lifevantage (LFVN)$175M
Pro-Dex (PDEX)$140M